Wuxi Biologics IPO in Hong Kong brings in $511m
Wuxi Biologics (Cayman) Inc. completed a successful IPO on the Hong Kong stock exchange on Tuesday, raising $511m.
Archives for June 15, 2017
Sanofi outlines €600m biologics manufacturing investment plan
Sanofi has said it will spend €600m ($673m) to increase capacity to make biologic drugs over the next three years.
Aimmune to make peanut allergy candidate in Florida, US
Aimmune Therapeutics has opened its commercial manufacturing facility in Florida, US, where it will manufacture its investigational peanut allergy treatment.
The World Bank invests in Indian Biopharma
The Indian government has announced a $250m investment in the development of biopharmaceuticals and medical devices to address public health concerns.